MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update
02 Mai 2024 - 1:00PM
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or
“MindMed”), a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders, announced
today that it plans to host a conference call on Wednesday, May 8,
2024, at 4:30 p.m. ET to provide a corporate update and review the
Company’s results for the first quarter ended March 31, 2024.
Listeners can register for the webcast via this link. Analysts
wishing to participate in the question and answer session should
use this link. A replay of the webcast will be available via the
Investor Relations section of the MindMed website,
https://ir.mindmed.co/, and archived for at least 30 days after the
webcast. Those who plan on participating are advised to join 15
minutes prior to the start time.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders. MindMed trades on NASDAQ under the symbol MNMD.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240502898236/en/
For Media: media@mindmed.co For Investors:
ir@mindmed.co
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024